ID LIPG_CANFA Reviewed; 398 AA. AC P80035; O02857; DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1998, sequence version 2. DT 04-NOV-2008, entry version 69. DE RecName: Full=Gastric triacylglycerol lipase; DE Short=Gastric lipase; DE Short=GL; DE EC=3.1.1.3; DE Flags: Precursor; GN Name=LIPF; OS Canis familiaris (Dog). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; OC Canis. OX NCBI_TaxID=9615; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Stomach; RX MEDLINE=99450174; PubMed=10520456; RA Vaganay S., Joliff G., Bertaux O., Toselli E., Devignes M.D., RA Benicourt C.; RT "The complete cDNA sequence encoding dog gastric lipase."; RL DNA Seq. 8:257-262(1998). RN [2] RP PROTEIN SEQUENCE OF 20-59. RX MEDLINE=92037652; PubMed=1935982; RA Carriere F., Moreau H., Raphel V., Laugier R., Benicourt C., RA Junien J.-L., Verger R.; RT "Purification and biochemical characterization of dog gastric RT lipase."; RL Eur. J. Biochem. 202:75-83(1991). RN [3] RP X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 20-396. RX MEDLINE=21648681; PubMed=11689574; DOI=10.1074/jbc.M109484200; RA Roussel A., Miled N., Berti-Dupuis L., Riviere M., Spinelli S., RA Berna P., Gruber V., Verger R., Cambillau C.; RT "Crystal structure of the open form of dog gastric lipase in complex RT with a phosphonate inhibitor."; RL J. Biol. Chem. 277:2266-2274(2002). CC -!- CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a CC carboxylate. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase CC family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; Y13899; CAA74198.1; -; mRNA. DR PIR; S19539; S19539. DR RefSeq; NP_001003209.1; -. DR UniGene; Cfa.3733; -. DR PDB; 1K8Q; X-ray; 2.70 A; A/B=21-396. DR PDBsum; 1K8Q; -. DR Ensembl; ENSCAFG00000015682; Canis familiaris. DR GeneID; 403867; -. DR KEGG; cfa:403867; -. DR HOVERGEN; P80035; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0004806; F:triacylglycerol lipase activity; IEA:EC. DR GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. DR InterPro; IPR006693; AB_hydro_lipase. DR InterPro; IPR000073; AB_hydrolase_1. DR InterPro; IPR008262; Lipase_AS. DR Pfam; PF04083; Abhydro_lipase; 1. DR Pfam; PF00561; Abhydrolase_1; 1. DR PROSITE; PS00120; LIPASE_SER; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Glycoprotein; Hydrolase; KW Lipid degradation; Secreted; Signal. FT SIGNAL 1 19 FT CHAIN 20 398 Gastric triacylglycerol lipase. FT /FTId=PRO_0000017765. FT ACT_SITE 172 172 Charge relay system. FT ACT_SITE 343 343 Charge relay system. FT ACT_SITE 372 372 Charge relay system. FT CARBOHYD 34 34 N-linked (GlcNAc...) (Potential). FT CARBOHYD 99 99 N-linked (GlcNAc...) (Potential). FT CARBOHYD 271 271 N-linked (GlcNAc...) (Potential). FT CARBOHYD 327 327 N-linked (GlcNAc...) (Potential). FT DISULFID 246 255 FT CONFLICT 39 39 I -> T (in Ref. 2; AA sequence). FT STRAND 23 25 FT HELIX 29 32 FT HELIX 35 41 FT STRAND 47 52 FT STRAND 56 64 FT TURN 72 76 FT STRAND 79 83 FT HELIX 90 93 FT STRAND 94 96 FT TURN 98 100 FT HELIX 102 108 FT STRAND 112 115 FT STRAND 126 130 FT TURN 135 138 FT HELIX 142 147 FT HELIX 149 161 FT STRAND 166 171 FT HELIX 173 184 FT HELIX 186 189 FT STRAND 192 199 FT HELIX 210 215 FT HELIX 219 225 FT STRAND 228 232 FT HELIX 236 244 FT TURN 245 247 FT TURN 249 251 FT HELIX 252 263 FT HELIX 267 269 FT HELIX 272 274 FT HELIX 275 279 FT HELIX 288 300 FT HELIX 311 318 FT STRAND 319 322 FT HELIX 328 330 FT STRAND 335 340 FT STRAND 344 346 FT HELIX 348 355 FT STRAND 361 367 FT HELIX 374 377 FT HELIX 381 384 FT HELIX 386 394 SQ SEQUENCE 398 AA; 45131 MW; E04D62F7518E386C CRC64; MWLLLTAASV ISTLGTTHGL FGKLHPTNPE VTMNISQMIT YWGYPAEEYE VVTEDGYILG IDRIPYGRKN SENIGRRPVA FLQHGLLASA TNWISNLPNN SLAFILADAG YDVWLGNSRG NTWARRNLYY SPDSVEFWAF SFDEMAKYDL PATIDFILKK TGQDKLHYVG HSQGTTIGFI AFSTNPKLAK RIKTFYALAP VATVKYTETL LNKLMLVPSF LFKLIFGNKI FYPHHFFDQF LATEVCSRET VDLLCSNALF IICGFDTMNL NMSRLDVYLS HNPAGTSVQN VLHWSQAVKS GKFQAFDWGS PVQNMMHYHQ SMPPYYNLTD MHVPIAVWNG GNDLLADPHD VDLLLSKLPN LIYHRKIPPY NHLDFIWAMD APQAVYNEIV SMMGTDNK //